Asthma Trial, Recruiting NCT05341726 Sponsor: Columbia University Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT05341726
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • You are 18 years old or older
  • You identify your race as Black (this includes African American, African, Caribbean, West Indian, or mixed race with Black as one part), and you identify your ethnicity as Hispanic or non-Hispanic
  • A doctor has diagnosed you with persistent asthma (meaning you were prescribed a daily inhaled steroid medication in the last 4 years), OR you have had a recent asthma flare-up such as an emergency room visit or a course of steroid pills, regardless of whether you take daily asthma medicine
  • You receive your asthma care at one of the partner community health clinics involved in this study
  • You score above a certain level on two short surveys — one measuring how well your asthma is currently controlled, and one measuring certain beliefs about asthma management (confirm with trial site)

For doctors/clinicians:

  • You are a clinician who regularly cares for adult patients with asthma

For loved ones of patients:

  • You have been named by a patient participant as their loved one
  • You are a family member or friend of that patient

Who may not be able to join:

For patients:

  • You do not speak English
  • You have a serious mental health condition that would make it difficult to take part in the study (confirm with trial site)
  • You have already taken part in a listening session connected to this study

For loved ones:

  • You do not speak English
  • You have a serious mental health condition that would make it difficult to take part in the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maureen George, PhD, Columbia University School of Nursing

Phone: 2123051175

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 January 2023
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean Asthma Control Questionnaire Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov